FAPI PET and liquid biopsy for bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether combining a special scan (FAPI PET) with a simple blood test (liquid biopsy) can better detect and manage bladder cancer. It aims to improve staging and treatment decisions for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- ECOG performance status less than 2 (meaning you are fully active or able to carry out light work)
- Able to undergo imaging tests like PET scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if two types of PET/MRI scans (one using FAPI tracer, another using FDG tracer) are better at finding and evaluating muscle-invasive bladder cancer. It may help doctors decide the best treatment for you.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This study uses a special PET scan called FAPI to help find or monitor solid tumors. It may help doctors see tumors more clearly and guide treatment decisions.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
This trial tests whether a special PET/CT scan using a tracer called FAPI can better detect if breast cancer has spread to lymph nodes under the arm after neoadjuvant treatment. If successful, it could guide more precise surgery and avoid unnecessary lymph node removal.
This study uses a special PET scan (FAPI-PET) during routine workup to help detect tumors and decide how far they may have spread. You may be able to take part if you need a staging or restaging scan and can safely complete the imaging.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.